Developer docs
API playgroundTry for free, no card

Search company profiles

Antaria

Full company profile

uuid000dcgq

Namestring
Antaria
Legal namestring
Antaria Luxembourg S.A.
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Antaria Pharma is a Luxembourg-domiciled (Antaria Luxembourg S.A., registered capital €440,000) specialty finance company founded in 2019 that provides alternative debt financing exclusively to pharmacists operating in France. The company was created from the partnership of a pharmacist and a banker to address a structural gap in French pharmacy financing, where traditional banks have tightened credit conditions and demand personal contributions and medical insurance that exclude many practitioners from ownership.

Its core product, the "Financement Libérateur" (Intelligent Financing), uses a "prêt in-fine" (interest-only) structure where borrowers pay only monthly interest tied to Euribor, with principal repayable at maturity over 6–12 year terms. This is wrapped around five lifecycle modules—Se Lancer (first installation), Grandir (expansion), Rebondir (no-insurance bounce-back), Se Libérer (cash-out liquidity in ~4 weeks), and Transmettre (succession)—plus an emerging Solution Zéro Apport™ for zero personal contribution. Crucially, Antaria holds no equity; its value derives from operating within French regulations that prohibit non-pharmacist capital ownership, making pure debt the only permissible structure for external financiers.

Revenue derives from interest income on the loan book, one-time structuring and file fees, and professional services (audit, feasibility, legal preparation, contract review, ongoing reporting). Distribution combines a website-based online simulator, an inside-sales phone team, ESSEC Business School training partnerships as a top-of-funnel channel for young pharmacists, and earned media across pharmacy press and BFM Business. The company has accompanied 100+ pharmacists since inception and operates with a 1–10 employee headcount from a Paris bureau while remaining legally headquartered in Luxembourg.

Short descriptiontext

Antaria Pharma is a Luxembourg-domiciled specialty financier providing alternative debt (prêt in-fine) solutions to French pharmacists across career stages, including installation, expansion, cash-out, and succession, with no equity ownership.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLuxembourg, Luxembourg
HQ citystring
Luxembourg
HQ countrystring
Luxembourg
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy financing, alternative lending, in-fine loans, healthcare practice acquisition, pharmacy succession planning
NAICS code2 codes
  • Mortgage and Nonmortgage Loan Brokers52231
  • Activities Related to Credit Intermediation5223
SIC code1 code
  • Loan Brokers6163
Product category
Pharmacy Financing / Specialty Lending
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Financing interest income
TypeSubscription Recurring
Description

Antaria Pharma structures debt financing for pharmacists with interest rates tied to monthly Euribor. The company earns interest income on the loans structured. Financing terms range from 6 to 12 years with monthly interest payments.

antaria-pharma.com
2Structuring fees
TypeOne Time License
Description

Initial file processing fees and structuring fees associated with financing arrangements. The company charges all-inclusive financing rate and pre-negotiated bank account fees as part of the financing package.

antaria-pharma.com
3Professional services
TypeProfessional Services
Description

Advisory and accompaniment services including transaction consulting, financial management advice, and ongoing support. Services include audit of target pharmacy, feasibility analysis, legal framework preparation, contract review, and monthly performance reporting.

antaria-pharma.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components15 values
Capital deployed (loan principal funded under the in-fine model), Personnel (transaction experts, lawyers, accountants, sales staff), Operations (compliance, structuring, file processing), Marketing or Sales (PR, content, partnership training programs), Technology or R&D (simulator platform, CRM, website), Infrastructure (Luxembourg HQ and Paris office)
Pricing details1 tier
1Financing solutions for all pharmacist profiles
ModelOtherBilling cadenceMonthly
Notes

Interest rates tied to monthly Euribor. Financing terms 6-12 years. Initial file fees and structuring fees apply. Monthly interest payments required. 50% of financing can be repaid without penalty at any time after subscription. Full repayment without penalty possible from year 6.

antaria-pharma.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Antaria provides alternative debt-financing solutions tailored to French pharmacists across all career stages, using an "in-fine" prêt structure where borrowers pay monthly interest only and repay principal at maturity. The offering combines the Financement Libérateur product family (Se Lancer, Grandir, Rebondir, Se Libérer, Transmettre) with a Solution Zéro Apport™ zero-contribution option and an end-to-end Accompagnement sur-mesure advisory service covering pharmacy audit, transaction execution, and ongoing financial management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Monthly payments reduced by more than 50%
+5 more records
Product overview1 text field

Antaria Pharma is a financial and strategic partner for pharmacists offering a unified financing ecosystem centered on its 'Financement Libérateur' (Intelligent Financing) product. The portfolio includes five distinct product modules addressing different career stages: 'Se Lancer' for young graduates, 'Grandir' for career acceleration, 'Rebondir' for those without loan insurance, 'Se Libérer' (Cash-out) for liquidity access, and 'Transmettre' for succession planning. An emerging 'Solution Zéro Apport™' aims to eliminate the personal contribution requirement. All products leverage a 'prêt in-fine' model preserving 100% capital ownership. Complementary services include tailored expert support (Accompagnement sur-mesure), an online investment simulator, and an ESSEC partnership for business education. The company does not take equity stakes in pharmacies.

Product and service8 records
1Financement Libérateur (Intelligent Financing)
CategoryPharmacy financing
Description

Core debt-financing product leveraging credit market access to structure prêt in-fine loans for French pharmacists, requiring monthly interest-only payments with flexible principal repayment at maturity over 6–12 year terms. The pharmacist retains 100% ownership of the pharmacy.

2Se Lancer (Career Launch for Young Graduates)
CategoryPharmacy financing
Description

Financing solution for newly graduated pharmacists to become owners of their first pharmacy, requiring approximately 10% personal contribution and providing access to experienced pharmacist partners.

3Grandir (Growth & Expansion)
CategoryPharmacy financing
Description

Career-acceleration financing for established pharmacists seeking to move toward larger pharmacy structures or co-invest with fellow pharmacists.

4Rebondir (Bounce Back for Uninsured Pharmacists)
CategoryPharmacy financing
Description

Financing for pharmacists refused by banks due to health issues; explicitly does not require medical insurance as a condition for obtaining credit.

5Se Libérer (Cash-Out Liquidity)
CategoryPharmacy financing
Description

Liquidity solution allowing pharmacists to access capital tied up in their pharmacy without selling it; funds delivered in approximately 4 weeks for purposes such as buying out partners or co-investing in new projects.

6Transmettre (Pharmacy Succession Transmission)
CategoryPharmacy financing
Description

Succession solution that pre-arranges buyer financing before a pharmacy sale, simplifying transmission and ensuring transaction completion for retiring pharmacists.

7Solution Zéro Apport™ (Zero-Contribution Financing)
CategoryPharmacy financing
Description

Zero-contribution financing variant exclusive to Antaria, designed so that absence of personal assets is no longer a blocking factor for young pharmacists acquiring a first pharmacy.

8Accompagnement sur-mesure (Tailored Expert Support)
CategoryAdvisory services
Description

End-to-end expert accompaniment from project audit and feasibility analysis through legal framework preparation, contract review, transaction execution, and post-financing management support; delivered by lawyers, accountants, and transaction specialists.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

Antaria Pharma has partnered with ESSEC Business School to offer a free 9-day training program in Management and Finance for pharmacy students and young pharmacists. The program, valued at €7,000, is delivered at ESSEC CNIT La Défense location. Reserved for 6th-year pharmacy students and pharmacists with less than 10 years of experience. Includes certificate from ESSEC Executive Education and access to Antaria expert network. This partnership positions Antaria as the strategic partner for young pharmacists' career development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Antaria

Pharmacy Financing / Specialty Lendingantaria-pharma.com

Antaria Pharma is a Luxembourg-domiciled specialty financier providing alternative debt (prêt in-fine) solutions to French pharmacists across career stages, including installation, expansion, cash-out, and succession, with no equity ownership.

What Antaria does

Antaria Pharma is a Luxembourg-domiciled (Antaria Luxembourg S.A., registered capital €440,000) specialty finance company founded in 2019 that provides alternative debt financing exclusively to pharmacists operating in France. The company was created from the partnership of a pharmacist and a banker to address a structural gap in French pharmacy financing, where traditional banks have tightened credit conditions and demand personal contributions and medical insurance that exclude many practitioners from ownership.

Its core product, the "Financement Libérateur" (Intelligent Financing), uses a "prêt in-fine" (interest-only) structure where borrowers pay only monthly interest tied to Euribor, with principal repayable at maturity over 6–12 year terms. This is wrapped around five lifecycle modules—Se Lancer (first installation), Grandir (expansion), Rebondir (no-insurance bounce-back), Se Libérer (cash-out liquidity in ~4 weeks), and Transmettre (succession)—plus an emerging Solution Zéro Apport™ for zero personal contribution. Crucially, Antaria holds no equity; its value derives from operating within French regulations that prohibit non-pharmacist capital ownership, making pure debt the only permissible structure for external financiers.

Revenue derives from interest income on the loan book, one-time structuring and file fees, and professional services (audit, feasibility, legal preparation, contract review, ongoing reporting). Distribution combines a website-based online simulator, an inside-sales phone team, ESSEC Business School training partnerships as a top-of-funnel channel for young pharmacists, and earned media across pharmacy press and BFM Business. The company has accompanied 100+ pharmacists since inception and operates with a 1–10 employee headcount from a Paris bureau while remaining legally headquartered in Luxembourg.

Antaria firmographics

Firmographics
Name
Antaria
Legal name
Antaria Luxembourg S.A.
Website
https://antaria-pharma.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Antaria Pharma is a Luxembourg-domiciled specialty financier providing alternative debt (prêt in-fine) solutions to French pharmacists across career stages, including installation, expansion, cash-out, and succession, with no equity ownership.
Ownership category
akta.pro rank

Where Antaria is headquartered

Location

Headquarters

HQ city
Luxembourg
HQ country
Luxembourg
HQ region
Europe

Offices3 records

Markets served

Antaria business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Capital deployed (loan principal funded under the in-fine model), Personnel (transaction experts, lawyers, accountants, sales staff), Operations (compliance, structuring, file processing), Marketing or Sales (PR, content, partnership training programs), Technology or R&D (simulator platform, CRM, website), Infrastructure (Luxembourg HQ and Paris office)

Revenue model

  1. Financing interest income: Antaria Pharma structures debt financing for pharmacists with interest rates tied to monthly Euribor. The company earns interest income on the loans structured. Financing terms range from 6 to 12 years with monthly interest payments.
  2. Structuring fees: Initial file processing fees and structuring fees associated with financing arrangements. The company charges all-inclusive financing rate and pre-negotiated bank account fees as part of the financing package.
  3. Professional services: Advisory and accompaniment services including transaction consulting, financial management advice, and ongoing support. Services include audit of target pharmacy, feasibility analysis, legal framework preparation, contract review, and monthly performance reporting.

Pricing tiers

ModelBillingPrice
OtherMonthlyFinancing solutions for all pharmacist profiles

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Antaria product offering

Product offering

Core offering

Antaria provides alternative debt-financing solutions tailored to French pharmacists across all career stages, using an "in-fine" prêt structure where borrowers pay monthly interest only and repay principal at maturity. The offering combines the Financement Libérateur product family (Se Lancer, Grandir, Rebondir, Se Libérer, Transmettre) with a Solution Zéro Apport™ zero-contribution option and an end-to-end Accompagnement sur-mesure advisory service covering pharmacy audit, transaction execution, and ongoing financial management.

Product overview

Antaria Pharma is a financial and strategic partner for pharmacists offering a unified financing ecosystem centered on its 'Financement Libérateur' (Intelligent Financing) product. The portfolio includes five distinct product modules addressing different career stages: 'Se Lancer' for young graduates, 'Grandir' for career acceleration, 'Rebondir' for those without loan insurance, 'Se Libérer' (Cash-out) for liquidity access, and 'Transmettre' for succession planning. An emerging 'Solution Zéro Apport™' aims to eliminate the personal contribution requirement. All products leverage a 'prêt in-fine' model preserving 100% capital ownership. Complementary services include tailored expert support (Accompagnement sur-mesure), an online investment simulator, and an ESSEC partnership for business education. The company does not take equity stakes in pharmacies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Financement Libérateur (Intelligent Financing) Core debt-financing product leveraging credit market access to structure prêt in-fine loans for French pharmacists, requiring monthly interest-only payments with flexible principal repayment at maturity over 6–12 year terms. The pharmacist retains 100% ownership of the pharmacy.
  • Se Lancer (Career Launch for Young Graduates) Financing solution for newly graduated pharmacists to become owners of their first pharmacy, requiring approximately 10% personal contribution and providing access to experienced pharmacist partners.
  • Grandir (Growth & Expansion) Career-acceleration financing for established pharmacists seeking to move toward larger pharmacy structures or co-invest with fellow pharmacists.
  • Rebondir (Bounce Back for Uninsured Pharmacists) Financing for pharmacists refused by banks due to health issues; explicitly does not require medical insurance as a condition for obtaining credit.
  • Se Libérer (Cash-Out Liquidity) Liquidity solution allowing pharmacists to access capital tied up in their pharmacy without selling it; funds delivered in approximately 4 weeks for purposes such as buying out partners or co-investing in new projects.
  • Transmettre (Pharmacy Succession Transmission) Succession solution that pre-arranges buyer financing before a pharmacy sale, simplifying transmission and ensuring transaction completion for retiring pharmacists.
  • Solution Zéro Apport™ (Zero-Contribution Financing) Zero-contribution financing variant exclusive to Antaria, designed so that absence of personal assets is no longer a blocking factor for young pharmacists acquiring a first pharmacy.
  • Accompagnement sur-mesure (Tailored Expert Support) End-to-end expert accompaniment from project audit and feasibility analysis through legal framework preparation, contract review, transaction execution, and post-financing management support; delivered by lawyers, accountants, and transaction specialists.

Quantifiable outcome

  • Monthly payments reduced by more than 50%
  • +5 more outcomes

Companies that use Antaria

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Antaria technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Antaria partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ESSEC Business SchoolcoreStrategic or Co-development Partner · 1 May 2026Antaria Pharma has partnered with ESSEC Business School to offer a free 9-day training program in Management and Finance for pharmacy students and young pharmacists. The program, valued at €7,000, is delivered at ESSEC CNIT La Défense location. Reserved for 6th-year pharmacy students and pharmacists with less than 10 years of experience. Includes certificate from ESSEC Executive Education and access to Antaria expert network. This partnership positions Antaria as the strategic partner for young pharmacists' career development.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Antaria competitors and assessment

Company assessment

Market position

Strengths1 record

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

Antaria social profiles

Digital presence

Antaria compliance and trust

Trust signal

Compliance1 record

Antaria financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Antaria leadership team

Management profile

Number of profiles

Antaria funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Antaria M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Antaria

What does Antaria do?

Antaria provides alternative debt-financing solutions tailored to French pharmacists across all career stages, using an "in-fine" prêt structure where borrowers pay monthly interest only and repay principal at maturity. The offering combines the Financement Libérateur product family (Se Lancer, Grandir, Rebondir, Se Libérer, Transmettre) with a Solution Zéro Apport™ zero-contribution option and an end-to-end Accompagnement sur-mesure advisory service covering pharmacy audit, transaction execution, and ongoing financial management.

Is Antaria a public or private company?

Antaria is a private company. It is classified as venture growth investor backed and is currently operating.

When was Antaria founded?

Antaria was founded in 2019. It employs 11 to 50 people.

Where is Antaria based?

Antaria is headquartered in Luxembourg, Luxembourg, in the Europe region.

How does Antaria make money?

Three revenue lines are on record. Financing interest income is the primary driver. The others are structuring fees and professional services.

Does Antaria have an API?

No public API is recorded for Antaria.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales